For gp100-specific clones, cytotoxicity was 70-90% against melanocytes versus 35-60% against melanoma (p = 0.08) by high RE clones, and 18-40% against melanocytes versus 15-25% against melanoma cell lines (p = 0.6) by intermediate RE clones. Here, PMEL is linked to melanoma.